Patient blood type, age, sex, smoking status, coffee consumption, comorbidities (such as DM and liver disease), and use of HMG-CoA reductase inhibitor or heparin usage can also affect vWF characteristics (32–39). This evidence concerns the gene VWF and diabetes mellitus.